Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged
Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged
Fund · US74016W8414 · NVOH (XNYS)
Overview
26,50 USD
1,07 % 0,28 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
01.08.2025 19:58

Current Prices from Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
NVOH
USD
01.08.2025 19:58
26,50 USD
0,28 USD
+1,07 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -29,97 % -28,30 % -25,52 % -26,18 % -26,18 % -26,18 %

Company Profile for Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged Fund

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.

Company Data

Name Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged
Company Precidian ETFs Trust Novo Nordi
Symbol NVOH
Website https://www.precidianetfs.com/etf/nvoh
Primary Exchange XNYS NYSE
ISIN US74016W8414
Asset Class Fund
Sector Healthcare
Industry Medical - Pharmaceuticals
Country Denmark
Currency USD
Employees -
Address Novo Allé 1, 2880 Bagsværd
IPO Date 2025-01-07

Ticker Symbols

Name Symbol
NYSE NVOH

More Shares

Investors who hold Precidian ETFs Trust Novo Nordisk A/S B Shares ADRhedged also have the following shares in their portfolio:
BEKARYS LIQ. 24/29 MTN
BEKARYS LIQ. 24/29 MTN Bond
UBS (LUX) BOND SICAV - SHORT TERM EUR CORPRATES (EUR) I-A3-ACC
UBS (LUX) BOND SICAV - SHORT TERM EUR CORPRATES (EUR) I-A3-ACC ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025